Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,691 | 101 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $291.00 | 21 | $0 (2024) |
| Novo Nordisk Inc | $263.57 | 15 | $0 (2024) |
| ABBVIE INC. | $255.52 | 13 | $0 (2024) |
| Lilly USA, LLC | $223.40 | 15 | $0 (2024) |
| Amarin Pharma Inc. | $98.84 | 6 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $86.20 | 5 | $0 (2022) |
| Melinta Therapeutics, Inc. | $66.39 | 4 | $0 (2019) |
| GlaxoSmithKline, LLC. | $65.83 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $53.06 | 3 | $0 (2023) |
| Exact Sciences Corporation | $38.98 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $473.96 | 25 | ABBVIE INC. ($139.43) |
| 2023 | $270.03 | 15 | ABBVIE INC. ($64.45) |
| 2022 | $172.63 | 10 | Boehringer Ingelheim Pharmaceuticals, Inc. ($48.85) |
| 2021 | $176.95 | 11 | Novo Nordisk Inc ($51.49) |
| 2020 | $294.67 | 19 | Novo Nordisk Inc ($82.85) |
| 2019 | $154.99 | 10 | Amarin Pharma Inc. ($37.27) |
| 2018 | $94.84 | 7 | Melinta Therapeutics, Inc. ($38.23) |
| 2017 | $53.28 | 4 | Novo Nordisk Inc ($26.25) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.83 | General |
| Category: Immunology | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Endocrinology | ||||||
| 08/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Obesity | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Respiratory | ||||||
| 06/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: RESPIRATORY | ||||||
| 06/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Diabetes | ||||||
| 06/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.13 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Oncology | ||||||
| 04/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $34.31 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Respiratory | ||||||
| 04/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Oncology | ||||||
| 03/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 649 | 990 | $102,444 | $29,312 |
| 2022 | 11 | 634 | 948 | $95,391 | $28,209 |
| 2021 | 12 | 685 | 1,024 | $89,357 | $27,497 |
| 2020 | 21 | 1,145 | 1,678 | $84,806 | $31,133 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 202 | 252 | $48,384 | $14,437 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 114 | $30,666 | $7,761 | 25.3% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 25 | 26 | $8,684 | $3,634 | 41.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 67 | 121 | $2,445 | $1,009 | 41.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 86 | 111 | $5,328 | $914.55 | 17.2% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 66 | 166 | $2,822 | $673.91 | 23.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 56 | 81 | $2,511 | $610.32 | 24.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 67 | 100 | $1,300 | $218.24 | 16.8% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 17 | 19 | $304.00 | $53.49 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 177 | 215 | $41,280 | $12,497 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 109 | $29,321 | $8,124 | 27.7% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 21 | 21 | $5,597 | $2,955 | 52.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 27 | 28 | $2,044 | $1,150 | 56.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $4,636 | $911.60 | 19.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 72 | 84 | $4,032 | $709.42 | 17.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 52 | 80 | $2,480 | $614.24 | 24.8% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 61 | 159 | $2,633 | $610.32 | 23.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 61 | 130 | $1,950 | $385.20 | 19.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 65 | 91 | $1,183 | $201.76 | 17.1% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2022 | 11 | 12 | $235.58 | $49.91 | 21.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 201 | 244 | $42,960 | $13,243 | 30.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 72 | 119 | $29,943 | $8,723 | 29.1% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 45 | 46 | $2,930 | $1,903 | 65.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 79 | 100 | $4,254 | $868.05 | 20.4% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2021 | 56 | 179 | $2,788 | $779.34 | 28.0% |
About Dr. Michael Montgomery, D.O
Dr. Michael Montgomery, D.O is a Family Medicine healthcare provider based in Clarksburg, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366553166.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Montgomery, D.O has received a total of $1,691 in payments from pharmaceutical and medical device companies, with $473.96 received in 2024. These payments were reported across 101 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,691).
As a Medicare-enrolled provider, Montgomery has provided services to 3,113 Medicare beneficiaries, totaling 4,640 services with total Medicare billing of $116,151. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Clarksburg, WV
- Active Since 08/31/2006
- Last Updated 04/06/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1366553166
Products in Payments
- FARXIGA (Drug) $161.09
- Ozempic (Drug) $152.22
- Vascepa (Drug) $98.84
- QULIPTA (Drug) $94.93
- UBRELVY (Drug) $93.42
- AIRSUPRA (Drug) $73.96
- STIOLTO RESPIMAT (Drug) $73.90
- Baxdela (Drug) $66.39
- MOUNJARO (Drug) $64.95
- TRULICITY (Drug) $60.91
- BREZTRI (Drug) $55.95
- JARDIANCE (Drug) $55.44
- XIFAXAN (Drug) $53.06
- TRELEGY ELLIPTA (Drug) $51.07
- BASAGLAR (Drug) $42.10
- Cologuard Collection Kit (Device) $38.98
- QUTENZA (Drug) $29.19
- REXULTI (Drug) $24.52
- Victoza (Drug) $24.41
- Tresiba (Drug) $23.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Clarksburg
Isha Woofter, M.d, M.D
Family Medicine — Payments: $29,661
Dominick Woofter, M.d, M.D
Family Medicine — Payments: $28,937
Dana Bragg, Md, MD
Family Medicine — Payments: $4,624
Ms. Jo Longenecker, M.d, M.D
Family Medicine — Payments: $3,137
Lea Angela Singzon, Md, MD
Family Medicine — Payments: $1,913
Dr. William Bowles, D.o, D.O
Family Medicine — Payments: $1,854